Tom Butler
Net worth: 4 M $ as of 29/06/2026
Net worth: 4 M $ as of 29/06/2026
Thomas Butler is the founder of Point Sur Investors LLC, founded in 2015, where the title held is Managing Member.
Mr. Butler was the founder of Biomea Fusion, Inc., founded in 2017, where the titles held were Chairman & Chief Executive Officer from 2017 to 2025.
Former jobs include Senior Manager-Investor Relations at Pharmacyclics LLC from 2013 to 2015.
Education history includes an MBA from the University of California, Los Angeles in 2012, an undergraduate degree from The California State University, and a graduate degree from the University of California, Santa Barbara in 2007.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 2,493,407 ( 3.5% ) | 4 M $ | 29/06/2026 |
| Companies | Position | Start |
|---|---|---|
Point Sur Investors LLC
Point Sur Investors LLC Investment ManagersFinance Provides investment advice | Founder | 31/12/2014 |
| Companies | Position | End |
|---|---|---|
| BIOMEA FUSION, INC. | Chief Executive Officer | 24/03/2025 |
| PHARMACYCLICS, INC. | Investor Relations Contact | 31/12/2014 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The California State University
The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Point Sur Investors LLC
Point Sur Investors LLC Investment ManagersFinance Provides investment advice | Finance |
Biomea Fusion, Inc.
Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers | Health Technology |
Select your edition
All financial news and data tailored to specific country editions